Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco.
Ali MirzazadehYea-Hung ChenJess LinKatie BurkErin C WilsonDesmond MillerDanielle VelosoWilli McFarlandMeghan D MorrisPublished in: PloS one (2021)
While findings indicate an improvement in HCV treatment uptake among PWID in San Francisco, more than half of PWID diagnosed with HCV infection had not received HCV treatment in 2018. Policies and interventions to increase coverage are necessary, particularly among PWID who are uninsured and outside of regular care.